Search Through All Notices
Joint Information Center – JIC Release No. 1120
August 25, 2022, 4:20 p.m. (ChST)
COVID-19 Test Results: 63 New Cases, 21 Hospitalized; Additional COVID-19 Updates
COVID-19 Test Results: 63 New Cases Reported
Today, the Department of Public Health and Social Services (DPHSS) reported 63 new cases of COVID-19 from 1,171 specimens collected August 24, 2022. Five (5) of the cases reported today are through the Department of Defense. To date, there have been a total of 57,599 officially reported cases, 389 deaths, 425 cases in active isolation, and 56,785 not in active isolation.
21 Hospitalized for COVID-19
SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 10 vaccinated people hospitalized for COVID-19 compared to 55 unvaccinated people hospitalized for COVID-19. The risk of being hospitalized for COVID-19 is about 6 times higher for the unvaccinated as compared to the vaccinated. *Estimated population is based on DPHSS Immunization Program analysis of 2020 Census data. Updates are expected pending further Census 2020 data breakdown.
Novavax COVID-19 Vaccine Available at Northern Region Community Health Center
On August 9, DPHSS received 100 doses of the Novavax COVID-19 vaccine. The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for the Novavax vaccine on July 13. According to the CDC, the Novavax vaccine is a two-dose adjuvanted vaccine that is administered intramuscularly in deltoid muscle in adults 18 years of age or older. The Novavax vaccine is a two-dose primary series with three to eight weeks between dose one and dose two. Currently, the Novavax vaccine is not authorized for any booster dose. In addition, individuals who complete their primary series with two doses of Novavax vaccine are not eligible for a booster dose at this time. The Novavax vaccine will be available at the DPHSS Northern Region Community Health Center in Dededo.
DPHSS mAb Treatment Center Open at Paseo Stadium
Bebtelovimab, a monoclonal antibody (mAb) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) is available at the DPHSS mAb treatment center at the Paseo Stadium in Hagåtña from 9 a.m. to 4 p.m., and closes for lunch from 12 p.m. to 1 p.m., Monday through Saturday.
To schedule treatment at the DPHSS mAb treatment center, patients must call 671-998-4527 or 671-998-4547, have a current, laboratory confirmed COVID–19 infection and a referral from a prescribing physician. For more information about Bebtelovimab and other mAb treatment options on Guam, visit dphss.guam.gov/mab or dial 311 from a local number and select option 1 on weekdays from 8 a.m. to 9 p.m. and on weekends and holidays from 8 a.m. to 5 p.m.
COVID-19 Vaccines for Children 6 Months and Older Available at DPHSS CHCs
The Moderna and the Pfizer-BioNTech COVID-19 Vaccines are authorized for use in children from six months of age and older. In most children, the Moderna COVID-19 vaccine for children ages six months through five years will be a two-dose primary series with four to eight weeks between dose one and dose two. In most children, the Pfizer-BioNTech COVID-19 vaccine for children ages six months through four years will be a three-dose primary series three to eight weeks between dose one and dose two, and at least eight weeks between dose two and dose three.
Requirements for minors to receive the Moderna or Pfizer-BioNTech COVID-19 Vaccine at DPHSS vaccination clinics and outreach events:
Incentives Offered for COVID-19 Vaccination Series Completion and Boosters
A program administered by the government of Guam is providing incentives to individuals 12 years of age and older who maintain their COVID-19 vaccinations who are completing their last dose in primary series; OR receiving 1st Booster Dose OR 2nd Booster Dose. Eligible residents will be offered an incentive (alcohol and tobacco items excluded) while supplies last. Gift certificates will only be offered at vaccination clinics at NRCHC, SRCHC, the Agana Shopping Center, and senior citizen outreach clinics, while supplies last.
Guam COVID-19 Vaccination Update
As of August 24, 2022, 139,866 eligible residents (6 months and older) are fully vaccinated. This total includes 14,024residents 12 – 17 years old. 9,030 residents 5 – 11 years old received their first dose of a two dose series. 7,374 residents 5 – 11 years old have completed their two-dose series. 203 residents 6 months – 4 years old have received their first dose of a two dose series. 70,010 eligible residents have received their first booster shots. 12,061 eligible residents have received their second booster shots.
-###-
For the latest information on COVID-19, visit dphss.guam.gov or guamrecovery.com. For inquiries, contact 311 through a local number, or call the Joint Information Center at (671) 478-0208/09/10.
August 25, 2022, 4:20 p.m. (ChST)
COVID-19 Test Results: 63 New Cases, 21 Hospitalized; Additional COVID-19 Updates
COVID-19 Test Results: 63 New Cases Reported
Today, the Department of Public Health and Social Services (DPHSS) reported 63 new cases of COVID-19 from 1,171 specimens collected August 24, 2022. Five (5) of the cases reported today are through the Department of Defense. To date, there have been a total of 57,599 officially reported cases, 389 deaths, 425 cases in active isolation, and 56,785 not in active isolation.
21 Hospitalized for COVID-19
| CENSUS as of 4 p.m. | GMH | GRMC | USNH | TOTAL |
|---|---|---|---|---|
| COVID-19 Admission | 13 | 8 | 0 | 21 |
| Pediatric Admissions | 1 | - | - | 1 |
| ICU | 4 | 0 | 0 | 4 |
| Ventilator | 1 | 0 | 0 | 1 |
| VACCINATION STATUS | VACCINATED | UNVACCINATED | INELIGIBLE (Under 6 months old) |
| Hospitalized | 14 | 7 | 0 |
| Total in Population* | 139,866 | 12,747 | 1,223 |
| Rate per 100,000 Population | 10 | 55 | 0 |
Novavax COVID-19 Vaccine Available at Northern Region Community Health Center
On August 9, DPHSS received 100 doses of the Novavax COVID-19 vaccine. The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for the Novavax vaccine on July 13. According to the CDC, the Novavax vaccine is a two-dose adjuvanted vaccine that is administered intramuscularly in deltoid muscle in adults 18 years of age or older. The Novavax vaccine is a two-dose primary series with three to eight weeks between dose one and dose two. Currently, the Novavax vaccine is not authorized for any booster dose. In addition, individuals who complete their primary series with two doses of Novavax vaccine are not eligible for a booster dose at this time. The Novavax vaccine will be available at the DPHSS Northern Region Community Health Center in Dededo.
DPHSS mAb Treatment Center Open at Paseo Stadium
Bebtelovimab, a monoclonal antibody (mAb) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) is available at the DPHSS mAb treatment center at the Paseo Stadium in Hagåtña from 9 a.m. to 4 p.m., and closes for lunch from 12 p.m. to 1 p.m., Monday through Saturday.
To schedule treatment at the DPHSS mAb treatment center, patients must call 671-998-4527 or 671-998-4547, have a current, laboratory confirmed COVID–19 infection and a referral from a prescribing physician. For more information about Bebtelovimab and other mAb treatment options on Guam, visit dphss.guam.gov/mab or dial 311 from a local number and select option 1 on weekdays from 8 a.m. to 9 p.m. and on weekends and holidays from 8 a.m. to 5 p.m.
|
FREE COVID-19 COMMUNITY TESTING Fill out a COVID-19 Testing Patient Assessment Form ahead of time, available at dphss.guam.gov/covid-19-testing. |
|
|
Tuesday, Thursday, and Saturday 8 a.m. - 11 a.m. |
Old Carnival Grounds, Tiyan, Barrigada NO SYMPTOMS NEEDED TO TEST FOR COVID-19 Four adults per vehicle. Bring a photo ID.Travel-related testing will not be offered. |
|
Tuesday & Thursday 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Travel-related testing not offered. Call (671) 828-7604/5/7518. |
|
Monday - Saturday 9 a.m. by appointment |
DPHSS Northern Region Community Health Center (NRCHC), Dededo By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Call (671) 635-7525/6 to schedule an appointment. |
|
FREE COVID-19 VACCINATION CLINICS FIRST, SECOND AND BOOSTER SHOTS AVAILABLE - Pfizer-BioNTech, Moderna, Johnson & Johnson, Novavax* |
|
|
Monday, Wednesday, and Friday 11 a.m. - 3 p.m. |
Agana Shopping Center (2nd Floor) – AGES 5 YEARS & OLDER ONLY Walk-in service only. Registration for appointments is no longer offered. Bring proof of identity. Last sign-in is at 2:30 p.m. or while supplies last. |
|
Monday - Thursday 9 a.m. - 5 p.m. Saturday: 9 a.m. - 12 p.m. |
DPHSS Northern Region Community Health Center (NRCHC), Dededo Last vaccine will be administered 30 minutes before closing. Walk-ins welcome. Curbside vaccination available for people with disabilities. *Novavax COVD-19 vaccine available only at NRCHC. |
|
Monday - Friday 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan Call (671) 828-7604/5/7518 to schedule an appointment. Last appointment is 30 minutes before closing. Priority is given to patients with appointments. Walk-ins welcome. |
COVID-19 Vaccines for Children 6 Months and Older Available at DPHSS CHCs
The Moderna and the Pfizer-BioNTech COVID-19 Vaccines are authorized for use in children from six months of age and older. In most children, the Moderna COVID-19 vaccine for children ages six months through five years will be a two-dose primary series with four to eight weeks between dose one and dose two. In most children, the Pfizer-BioNTech COVID-19 vaccine for children ages six months through four years will be a three-dose primary series three to eight weeks between dose one and dose two, and at least eight weeks between dose two and dose three.
Requirements for minors to receive the Moderna or Pfizer-BioNTech COVID-19 Vaccine at DPHSS vaccination clinics and outreach events:
- Parent/legal guardian must provide minor’s birth certificate
- Parent/legal guardian must have a government-issued photo identification
- Minor must be accompanied by a parent or legal guardian
- Guardians must present legal guardianship or power-of-attorney documents
Incentives Offered for COVID-19 Vaccination Series Completion and Boosters
A program administered by the government of Guam is providing incentives to individuals 12 years of age and older who maintain their COVID-19 vaccinations who are completing their last dose in primary series; OR receiving 1st Booster Dose OR 2nd Booster Dose. Eligible residents will be offered an incentive (alcohol and tobacco items excluded) while supplies last. Gift certificates will only be offered at vaccination clinics at NRCHC, SRCHC, the Agana Shopping Center, and senior citizen outreach clinics, while supplies last.
Guam COVID-19 Vaccination Update
As of August 24, 2022, 139,866 eligible residents (6 months and older) are fully vaccinated. This total includes 14,024residents 12 – 17 years old. 9,030 residents 5 – 11 years old received their first dose of a two dose series. 7,374 residents 5 – 11 years old have completed their two-dose series. 203 residents 6 months – 4 years old have received their first dose of a two dose series. 70,010 eligible residents have received their first booster shots. 12,061 eligible residents have received their second booster shots.
-###-
For the latest information on COVID-19, visit dphss.guam.gov or guamrecovery.com. For inquiries, contact 311 through a local number, or call the Joint Information Center at (671) 478-0208/09/10.
